All In MedTech

Free tool

FDA Breakthrough Devices

FDA's Breakthrough Devices Program speeds review of devices that may treat or diagnose life-threatening or irreversibly debilitating conditions better than existing options. FDA only names designated devices once they are authorized; designations still in review stay confidential. Designated devices can also qualify for Medicare's TCET coverage pathway and, in some cases, a New Technology Add-on Payment.

Last checked: Nov 20, 2026FDA Breakthrough Devices Program list last updated: June 30, 2026 (fetched 2026-11-11)

Authorized Breakthrough devices

206

Through June 30, 2026

Via De Novo

51

25% of authorizations

Via 510(k)

92

45% of authorizations

Via PMA

63

31% of authorizations

Authorizations by year

Select a year to filter the list.

8 more in this ranking with a free account

Top specialties

From each device's FDA review panel, where the device is in our catalog.

  • Cardiology46
  • Laboratory Medicine & Pathology42
  • Orthopedic Surgery32

7 more in this ranking with a free account

15 devices authorized in 2021

Clear filters
  • CAVACLEAR LASER SHEATH

    SPECTRANETICS, INC. · De Novo DEN210024 · Laser-Powered Inferior Vena Cava Filter Retrieval Catheter

    12/21/2021
  • KOIOS DS

    KOIOS MEDICAL, INC. · 510(k) K212616 · Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer

    12/16/2021
  • EASEVRX

    APPLIEDVR, INC. · De Novo DEN210014 · Virtual Reality Behavioral Therapy Device For Pain Relief

    11/16/2021

12 more devices with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.